Register Login
Register to leave comments
  • News bot Aug. 10, 2026, 8:41 p.m.

    📋 DIAMEDICA THERAPEUTICS INC. (DMAC) - Financial Results

    Filing Date: 2026-08-10

    Accepted: 2026-08-10 16:35:21

    Event Type: Financial Results

    Event Details:

    DIAMEDICA THERAPEUTICS INC. (DMAC) Reports the reporting period Financial Results DIAMEDICA THERAPEUTICS INC. (DMAC) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 29790
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 5129
      • Onset Fetal Growth Restriction Trial; Key Opinion Leader Call and Topline Results to Be Held in September ●Positive Topline Results from Phase 2 Late
      • Onset Preeclampsia Part 1a Dose
      • Extension Cohort, Demonstrating Rapid, Clinically Meaningful, and Statistically Significant Reductions in Maternal Blood Pressure ●Enrollment for Acute Ischemic Stroke Phase 2/3 Trial Progressing with Interim Analysis Anticipated Q1 2027 ●$
        • expected in September or October 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Other Income Net 314.00 813.00 $-499.00 -61.38%
    Net Loss 7.70K 20.18K $-12.48K -61.85%
    Current Assets Prepaid Expenses Other Current Assets 567.00 481.00 $86.00 +17.88%
    Noncurrent Assets Operating Lease Right Of Use Assets 400.00 400.00 $0.00 +0.00%
    Noncurrent Assets Property Equipment Net 153.00 197.00 $-44.00 -22.34%
    Current Liabilities Accounts Payable 2.81K 1.48K $1.34K +90.64%
    Current Liabilities Accrued Liabilities 3.67K 3.54K $121.00 +3.41%
    Cash Flows From Operating Activities Net Loss 20.18K 15.41K $4.78K +30.99%
    Changes In Operating Assets And Liabilities Prepaid Expenses Other Current Assets 86.00 453.00 $-367.00 -81.02%
    Changes In Operating Assets And Liabilities Accounts Payable 1.34K 321.00 $1.02K +316.51%
    Other Income, Net 366.00 314.00 $52.00 +16.56%
    Net Loss 10.14K 7.70K $2.44K +31.69%
    Other Assets 567.00 481.00 $86.00 +17.88%
    Property and Equipment, Net 153.00 197.00 $-44.00 -22.34%
    Accounts Payable 2.81K 1.48K $1.34K +90.64%
    Accrued Liabilities 3.67K 3.54K $121.00 +3.41%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: DIAMEDICA THERAPEUTICS INC.
    • Ticker Symbol: DMAC

Search

News categories